* Sabra Health Care REIT Inc SBRA.OQ SBRA.O is expected
to show a rise in quarterly revenue when it reports results on
August 7.
* The Irvine California-based company is expected to report
a
1.6% increase in revenue to $158.422 million from $155.96
million a year ago, according to the mean estimate from 9
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Sabra Health Care
REIT
Inc is for earnings of 10 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 9
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Sabra
Health Care
REIT Inc is $13, above its last closing price of $12.78.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 0.34 0.34 0.33 Missed -4
Dec. 31 2023 0.35 0.36 0.37 Beat 4.1
Sep. 30 2022 0.37 0.37 0.36 Missed -3.2
Jun. 30 2022 0.38 0.38 0.39 Beat 3.6
Mar. 0.38 0.38 0.38 Met -0.7
31 2022
Dec. 31 2021 0.36 0.37 0.39 Beat 5.7
Sep. 30 2021 0.39 0.39 0.38 Missed -2.2
Jun. 30 2021 0.39 0.39 0.39 Met -1.2
This summary was machine generated August 5 at 02:38 GMT. All
figures in US dollars unless otherwise stated